• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉脱维亚与铅相关的感染性心内膜炎:单中心经验。

Lead-Related Infective Endocarditis in Latvia: A Single Centre Experience.

机构信息

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Riga LV-1002, Latvia.

Faculty of Medicine, Riga Stradins University, Riga LV-1007, Latvia.

出版信息

Medicina (Kaunas). 2019 Sep 3;55(9):566. doi: 10.3390/medicina55090566.

DOI:10.3390/medicina55090566
PMID:31484433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6780120/
Abstract

: Over the last five decades cardiac implantable electronic devices (CIED) have become established as the mainstay for the treatment of permanent bradycardias, chronic heart failure and dangerous heart rhythm disturbances. These devices improve survival and quality of life in many patients. However, infections associated with CIED implantation, particularly lead-related infective endocarditis (LRIE), can offset all benefits and make more harm than good for the patient. To date, there are no other studies in Latvia, addressing patients with lead-related infective endocarditis. The objective of this study was to identify the most common pathogens associated with LRIE and their antimicrobial resistance and to identify possible risk factors of patients who present with LRIE. The study was performed retrospectively at Pauls Stradins Clinical University Hospital (PSCUH). The study included patients who were referred to PSCUH due to LRIE for lead extraction. Patients were identified from procedural journals. Information about isolated microorganisms, patient comorbidities and visual diagnostics data was taken from patient records. Forty-nine patients with CIED related infective endocarditis were included in the study, 34 (69.4%) were male, median age of all patients was 65.0 (50.5-73.0) years, median hospital stay was 15.5 (22.0-30.5) days. Successful and complete lead extraction was achieved in all patients. Thirty-two (65.3%) had received antibiotics prior to blood sample. Only in 31 (63.3%) positive culture results were seen. The most common isolated pathogens were (23.5%) and coagulase negative staphylococci (23.5%). Other bacteria were isolated considerably less often. The atrial lead was most common location for lead vegetations, seen in 50.0% of cases. Five (10.2%) patients have died due to the disease. Lead-related infective endocarditis is a major complication of cardiac implantable electronic devices with considerable morbidity and mortality, which in our study was as high as 10.2%.

摘要

在过去的五十年中,心脏植入式电子设备(CIED)已成为治疗永久性心动过缓、慢性心力衰竭和危险心律紊乱的主要手段。这些设备改善了许多患者的生存率和生活质量。然而,与 CIED 植入相关的感染,特别是与导线相关的感染性心内膜炎(LRIE),可能会抵消所有益处,并对患者造成弊大于利的影响。迄今为止,拉脱维亚尚无其他研究针对与导线相关的感染性心内膜炎患者。本研究的目的是确定与 LRIE 相关的最常见病原体及其抗菌药物耐药性,并确定出现 LRIE 的患者的可能危险因素。该研究在保拉斯·斯特拉津斯临床大学医院(PSCUH)进行回顾性研究。该研究纳入了因 LRIE 而转诊至 PSCUH 进行导线拔除的患者。患者从程序杂志中被识别。从患者记录中获取有关分离微生物、患者合并症和影像学诊断数据的信息。本研究共纳入 49 例 CIED 相关感染性心内膜炎患者,其中 34 例(69.4%)为男性,所有患者的中位年龄为 65.0(50.5-73.0)岁,中位住院时间为 15.5(22.0-30.5)天。所有患者均成功完成了完全的导线拔除。32 例(65.3%)在采血前接受了抗生素治疗。仅在 31 例(63.3%)中观察到阳性培养结果。最常见的分离病原体是 (23.5%)和凝固酶阴性葡萄球菌(23.5%)。其他细菌的分离率要低得多。心房导线是导线赘生物最常见的部位,见于 50.0%的病例。5 例(10.2%)患者因该疾病死亡。与心脏植入式电子设备相关的感染性心内膜炎是一种严重的并发症,具有相当高的发病率和死亡率,在我们的研究中高达 10.2%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0738/6780120/ea6a1f35648c/medicina-55-00566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0738/6780120/3c02b602992d/medicina-55-00566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0738/6780120/ea6a1f35648c/medicina-55-00566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0738/6780120/3c02b602992d/medicina-55-00566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0738/6780120/ea6a1f35648c/medicina-55-00566-g002.jpg

相似文献

1
Lead-Related Infective Endocarditis in Latvia: A Single Centre Experience.拉脱维亚与铅相关的感染性心内膜炎:单中心经验。
Medicina (Kaunas). 2019 Sep 3;55(9):566. doi: 10.3390/medicina55090566.
2
Lead-related infective endocarditis: Factors influencing early and long-term survival in patients undergoing transvenous lead extraction.铅相关感染性心内膜炎:影响经静脉拔除导线患者早期和长期生存的因素。
Heart Rhythm. 2017 Jan;14(1):43-49. doi: 10.1016/j.hrthm.2016.10.007. Epub 2016 Oct 7.
3
The emergence of Staphylococcus aureus as the primary cause of cardiac device-related infective endocarditis.金黄色葡萄球菌成为心内器械相关感染性心内膜炎的主要病因。
Infection. 2021 Oct;49(5):999-1006. doi: 10.1007/s15010-021-01634-5. Epub 2021 Jun 5.
4
Early, Delayed and Late Cardiac Implantable Electronic Device Infections: Do the Timing of Onset and Pathogens Matter?早期、延迟和晚期心脏植入式电子设备感染:发病时间和病原体有影响吗?
J Clin Med. 2022 Jul 6;11(14):3929. doi: 10.3390/jcm11143929.
5
Infectious complications in patients with cardiac implantable electronic devices: risk factors, prevention, and prognosis.心脏植入式电子设备患者的感染性并发症:危险因素、预防和预后。
Pol Arch Intern Med. 2017 Sep 29;127(9):597-607. doi: 10.20452/pamw.4065. Epub 2017 Jul 19.
6
Lead-related infective endocarditis: factors influencing the formation of large vegetations.铅相关性感染性心内膜炎:影响大型赘生物形成的因素。
Europace. 2017 Jun 1;19(6):1022-1030. doi: 10.1093/europace/euw121.
7
Outcomes in patients with definite and possible infective endocarditis related to a cardiac implantable electronic device.与心脏植入式电子设备相关的明确和可能感染性心内膜炎患者的结局。
Pol Arch Intern Med. 2024 Aug 8;134(7-8). doi: 10.20452/pamw.16775. Epub 2024 Jun 17.
8
Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves.人工心脏瓣膜患者心血管植入式电子设备感染经静脉导线拔除的结局
Circ Arrhythm Electrophysiol. 2016 Sep;9(9). doi: 10.1161/CIRCEP.116.004188.
9
Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study.心脏植入式电子设备患者的感染性心内膜炎:一项全国性研究。
Europace. 2020 Jul 1;22(7):1062-1070. doi: 10.1093/europace/euaa076.
10
Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population.与装置相关的感染性心内膜炎,特别考虑在以男性为主的人群中植入的血管内和心脏装置。
Scand J Infect Dis. 2012 Oct;44(10):753-60. doi: 10.3109/00365548.2012.678882. Epub 2012 Jun 10.

引用本文的文献

1
Native valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies.自体瓣膜、人工瓣膜及心脏装置相关感染性心内膜炎:当前创新诊断与治疗策略的综述与更新
Front Cell Dev Biol. 2022 Oct 3;10:995508. doi: 10.3389/fcell.2022.995508. eCollection 2022.
2
Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device-Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017.2003 年至 2017 年全国范围内心血管植入电子设备相关感染性心内膜炎、人工瓣膜心内膜炎和原生瓣膜心内膜炎患者的住院结局:一项全国性研究。
J Am Heart Assoc. 2022 Sep 6;11(17):e025600. doi: 10.1161/JAHA.122.025600. Epub 2022 Aug 24.

本文引用的文献

1
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.2017年心律学会心血管植入式电子装置导线管理与拔除专家共识声明
Heart Rhythm. 2017 Dec;14(12):e503-e551. doi: 10.1016/j.hrthm.2017.09.001. Epub 2017 Sep 15.
2
Identification of causative organism in cardiac implantable electronic device infections.心脏植入式电子设备感染中致病微生物的鉴定
J Cardiol. 2017 Nov;70(5):411-415. doi: 10.1016/j.jjcc.2017.03.006. Epub 2017 Apr 25.
3
Lead extractions in patients with cardiac implantable electronic device infections: Single center experience.
心脏植入式电子设备感染患者的导线拔除:单中心经验
J Arrhythm. 2016 Aug;32(4):308-12. doi: 10.1016/j.joa.2016.02.004. Epub 2016 Mar 22.
4
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).2015年欧洲心脏病学会(ESC)感染性心内膜炎管理指南:欧洲心脏病学会(ESC)感染性心内膜炎管理工作组。认可机构:欧洲心胸外科学会(EACTS)、欧洲核医学协会(EANM)。
Eur Heart J. 2015 Nov 21;36(44):3075-3128. doi: 10.1093/eurheartj/ehv319. Epub 2015 Aug 29.
5
Predictors of mortality in patients with cardiovascular implantable electronic device infections.心血管植入式电子设备感染患者的死亡率预测因素。
Am J Cardiol. 2013 Mar 15;111(6):874-9. doi: 10.1016/j.amjcard.2012.11.052. Epub 2012 Dec 29.
6
Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.心脏植入式电子设备感染后的长期结局:一项前瞻性匹配队列研究。
Heart. 2012 May;98(9):724-31. doi: 10.1136/heartjnl-2012-301627.
7
The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project.第11次心脏起搏与植入式心律转复除颤器全球调查:2009日历年——一项世界心律失常学会的项目
Pacing Clin Electrophysiol. 2011 Aug;34(8):1013-27. doi: 10.1111/j.1540-8159.2011.03150.x. Epub 2011 Jun 27.
8
Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients.起搏器植入后的感染:在一项基于人群的队列研究中,对 46299 例连续患者的感染率和与感染相关的危险因素分析。
Eur Heart J. 2011 Apr;32(8):991-8. doi: 10.1093/eurheartj/ehq497. Epub 2011 Jan 20.
9
Cardiac implantable electronic device infections: presentation, management, and patient outcomes.心脏植入式电子设备感染:表现、处理和患者预后。
Heart Rhythm. 2010 Aug;7(8):1043-7. doi: 10.1016/j.hrthm.2010.05.016. Epub 2010 May 12.
10
Risk factors and time delay associated with cardiac device infections: Leiden device registry.与心脏设备感染相关的危险因素和时间延迟:莱顿设备登记处
Heart. 2009 May;95(9):715-20. doi: 10.1136/hrt.2008.151985. Epub 2008 Nov 26.